Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of drug for treating cerebrovascular disease sequelae

A technology for cerebrovascular disease and sequelae, applied in the field of medicine, can solve problems such as long treatment cycle, high cost, and poor treatment effect, and achieve effective treatment, obvious effect, and reasonable composition

Inactive Publication Date: 2015-08-05
孙景芝
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, a small amount of western medicine is used to treat the sequelae of cerebrovascular disease, but long-term infusion, taking antihypertensive and blood lipid-lowering drugs can only lower blood pressure and relieve heart function, but cannot remove thrombus, dilate blood vessels, nourish qi and blood, Good circulatory effects such as sperm production and fluid production, the treatment effect is not good, the treatment cycle is long, and the cost is high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0010] Example Preparation of the decoction of the present invention

[0011] Take 90 grams of Lamb Qilian, 80 grams of Cycas fern, 80 grams of Guojiang Longzi, 70 grams of Dushangshan, 70 grams of Ling vanilla, 60 grams of chicken tendon, 60 grams of green sky sunflower, 50 grams of medicinal inverted pot, 50 grams of bell beans, 30 grams of yellow water sticks, 20 grams of sugar root and 10 grams of licorice, add 11,000 ml of water, heat for 6 hours under reflux conditions, filter, and cool the filtrate to room temperature.

experiment example

[0013] Diagnostic criteria

[0014] The diagnostic standard of Chinese medicine adopts "Stroke Diagnosis and Efficacy Evaluation Criteria" (Ren Zhanli, Wang Shundao. Diagnosis and Efficacy Evaluation Criteria of Stroke. Journal of Beijing University of Chinese Medicine, 1996, 19(1); 55-56.), Western medicine diagnostic criteria reference "Key points in the diagnosis of various cerebrovascular diseases" (Wang Xinde. Key points in the diagnosis of various cerebrovascular diseases. Chinese Journal of Neurology, 1996, 29(6); 379-381.).

[0015] standard constrain

[0016] ① 24 hours after the onset of cerebral thrombosis, 48 ​​hours after the onset of cerebral hemorrhage, the sequelae of cerebrovascular disease was confirmed by CT. The infarct position is in the basal ganglia and temporal lobe, and the infarct range is ≤18cm 2 . The bleeding site is in the basal ganglia, subarachnoid space, brain lobe, cerebellum, and the amount of bleeding is ≤20ml; ②The syndrome differentiation of tr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a preparation method of a drug for treating cerebrovascular disease sequelae. The preparation method comprises the following steps: taking 90g of colysis elliptica, 80g of brainea insignis, 80g of bauhinia seed, 70g of maesa japonica, 70g of lysimachia foenum-graecum, 60g of damnacanthus macrophyllus sieb.ex mig.var giganteus(makion)koidz, 60g of nervilia fordii, 50g of dog bur, 50g of crotalaria albida, 30g of tiarella polyphylla, 20g of capitellate hedyotis herb and 10g of liquorice; adding 11000ml of water to heat under backflow condition for 6h; and filtering an cooling the filtrate to room temperature. The drug for treating cerebrovascular disease sequelae is reasonable in composition and remarkable in effect and can be used for effectively treating the cerebrovascular disease sequelae.

Description

Technical field [0001] The invention relates to the field of medicine, in particular to a method for preparing a medicine for treating sequelae of cerebrovascular disease. Background technique [0002] Cerebrovascular disease refers to a group of diseases with cerebral hemorrhagic or ischemic injury symptoms as the main clinical manifestations caused by rupture of cerebral blood vessels or thrombosis. It is commonly known as "stroke". The disease is relatively high among middle-aged and elderly people. The incidence rate is more men than women. After the disease has been treated in the hospital in time and reached clinical treatment, there will still be sequelae such as mild paralysis or hemiplegia, limb numbness, sensory disturbance, movement disorder, dysphonia, ataxia, dizziness, tinnitus, diplopia and other sequelae. At present, a small amount of western medicine is used to treat the sequelae of cerebrovascular disease, and long-term infusion, taking antihypertensive and hyp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/898A61P9/10A61P25/00
Inventor 蒋晓云
Owner 孙景芝
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com